Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

Valerio De Stefano, M. Ruggeri, A. Tosetto, F. Palandri, N. Polverelli, M. G. Mazzucconi, C. Santoro, G. Gaidano, M. Lunghi, F. Zaja, R. Sartori, P. Fazi, F. Rodeghiero

Risultato della ricerca: Contributo in rivistaArticolo in rivista

58 Citazioni (Scopus)

Abstract

An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases.
Lingua originaleEnglish
pagine (da-a)1266-1273
Numero di pagine8
RivistaJournal of Thrombosis and Haemostasis
Volume12
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • TMP mimetic peptide
  • epidemiology
  • immune thrombocytopenic purpura
  • splenectomy
  • thrombosis

Fingerprint

Entra nei temi di ricerca di 'Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors'. Insieme formano una fingerprint unica.

Cita questo